Skystar Bio-Pharma (SKBI) Income Statement

Click line-items for a historical chart and %

REVENUE, NET	18.35M
COST OF REVENUE	9.59M
GROSS PROFIT	8.76M
Research and development	378.49K
Selling expenses	1.08M
General and administrative	1.9M
Total operating expenses	3.36M
INCOME FROM OPERATIONS	5.4M
Other income (expense), net	4.81K
Interest income (expense), net	-252.16K
Change in fair value of derivative liability
Total other income (expense), net	222.81K
INCOME BEFORE PROVISION FOR INCOME TAXES
PROVISION FOR INCOME TAXES	712.93K
NET INCOME	4.91M
Foreign currency translation adjustment	-4.94K
COMPREHENSIVE INCOME	4.9M
Basic (in dollars per share)	0.58
Diluted (in dollars per share)	0.57
Basic (in shares)	8.49M
Diluted (in shares)	8.57M

Entities mentioned with SKBI

View All Entities